Lilly pill cuts genetic form of cholesterol nearly 86% in study
Lilly's drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk factor for heart disease that affects one in five individuals globally
Weight-loss drug forecasts jump to $150 billion as supply grows
US FDA authorizes Eli Lilly's Covid-19 antibody drug
Lilly withdraws from EU rolling review of Covid-19 antibodies
Eli Lilly to donate 400,000 tablets of its Covid-19 treatment to India
Eli Lilly's antibody combination receives FDA emergency use authorization for Covid-19
Eli Lilly strikes optimistic tone on Covid-19 therapy after trial failure
Second Covid-19 trial paused within 24 hours over safety concerns
Antibody drugs are no cure but seem promising for Covid-19
Eli Lilly in deal to supply Covid-19 drugs to low-income countries
Lilly partners with Amgen for manufacturing potential Covid-19 drugs
Lilly says antibody reduces need for hospitalization for moderate Covid-19 patients